Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer
10.1186/s12885-015-1718-7
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181428 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-181428 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1814282024-11-10T17:21:19Z Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer Matula, K Collie-Duguid, E Murray, G Parikh, K Grabsch, H Tan, P Lalwani, S Garau, R Ong, Y Bain, G Smith, A.-D Urquhart, G Bielawski, J Finnegan, M Petty, R DUKE-NUS MEDICAL SCHOOL antineoplastic agent biological marker capecitabine cisplatin docetaxel epirubicin glycosphingolipid messenger RNA oxaliplatin protein p53 safingol sphingolipid sphingosine 1 phosphate sphingosine 1 phosphate lyase sphingosine kinase 1 unclassified drug antineoplastic agent lyase lysophospholipid phosphotransferase RNA sphingosine sphingosine 1-phosphate sphingosine 1-phosphate lyase (aldolase) sphingosine kinase Article cancer cell line cancer combination chemotherapy cancer inhibition cancer patient cancer staging cancer surgery cancer survival carcinogenesis cell compartmentalization controlled study disease association drug cytotoxicity drug efficacy drug potentiation drug safety drug sensitivity drug tolerability enzyme regulation esophageal adenocarcinoma esophageal squamous cell carcinoma esophagus cancer exon gastroesophageal cancer gene gene expression high performance liquid chromatography human human cell human tissue IC50 immunohistochemistry lysosome monotherapy multiple cycle treatment phase 1 clinical trial protein expression quantitative analysis reverse transcription polymerase chain reaction SGPL1 gene signal transduction sphingolipid metabolism SPHK1 gene stomach adenocarcinoma stomach cancer survival time analogs and derivatives biosynthesis drug resistance Esophageal Neoplasms female gene expression regulation genetics male metabolism real time polymerase chain reaction Stomach Neoplasms tumor cell line Aldehyde-Lyases Antineoplastic Agents Cell Line, Tumor Drug Resistance, Neoplasm Esophageal Neoplasms Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Lysophospholipids Male Phosphotransferases (Alcohol Group Acceptor) Real-Time Polymerase Chain Reaction RNA, Neoplasm Signal Transduction Sphingosine Stomach Neoplasms 10.1186/s12885-015-1718-7 BMC Cancer 15 1 762 2020-10-27T10:53:42Z 2020-10-27T10:53:42Z 2015 Article Matula, K, Collie-Duguid, E, Murray, G, Parikh, K, Grabsch, H, Tan, P, Lalwani, S, Garau, R, Ong, Y, Bain, G, Smith, A.-D, Urquhart, G, Bielawski, J, Finnegan, M, Petty, R (2015). Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer. BMC Cancer 15 (1) : 762. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1718-7 14712407 https://scholarbank.nus.edu.sg/handle/10635/181428 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
antineoplastic agent biological marker capecitabine cisplatin docetaxel epirubicin glycosphingolipid messenger RNA oxaliplatin protein p53 safingol sphingolipid sphingosine 1 phosphate sphingosine 1 phosphate lyase sphingosine kinase 1 unclassified drug antineoplastic agent lyase lysophospholipid phosphotransferase RNA sphingosine sphingosine 1-phosphate sphingosine 1-phosphate lyase (aldolase) sphingosine kinase Article cancer cell line cancer combination chemotherapy cancer inhibition cancer patient cancer staging cancer surgery cancer survival carcinogenesis cell compartmentalization controlled study disease association drug cytotoxicity drug efficacy drug potentiation drug safety drug sensitivity drug tolerability enzyme regulation esophageal adenocarcinoma esophageal squamous cell carcinoma esophagus cancer exon gastroesophageal cancer gene gene expression high performance liquid chromatography human human cell human tissue IC50 immunohistochemistry lysosome monotherapy multiple cycle treatment phase 1 clinical trial protein expression quantitative analysis reverse transcription polymerase chain reaction SGPL1 gene signal transduction sphingolipid metabolism SPHK1 gene stomach adenocarcinoma stomach cancer survival time analogs and derivatives biosynthesis drug resistance Esophageal Neoplasms female gene expression regulation genetics male metabolism real time polymerase chain reaction Stomach Neoplasms tumor cell line Aldehyde-Lyases Antineoplastic Agents Cell Line, Tumor Drug Resistance, Neoplasm Esophageal Neoplasms Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Lysophospholipids Male Phosphotransferases (Alcohol Group Acceptor) Real-Time Polymerase Chain Reaction RNA, Neoplasm Signal Transduction Sphingosine Stomach Neoplasms |
spellingShingle |
antineoplastic agent biological marker capecitabine cisplatin docetaxel epirubicin glycosphingolipid messenger RNA oxaliplatin protein p53 safingol sphingolipid sphingosine 1 phosphate sphingosine 1 phosphate lyase sphingosine kinase 1 unclassified drug antineoplastic agent lyase lysophospholipid phosphotransferase RNA sphingosine sphingosine 1-phosphate sphingosine 1-phosphate lyase (aldolase) sphingosine kinase Article cancer cell line cancer combination chemotherapy cancer inhibition cancer patient cancer staging cancer surgery cancer survival carcinogenesis cell compartmentalization controlled study disease association drug cytotoxicity drug efficacy drug potentiation drug safety drug sensitivity drug tolerability enzyme regulation esophageal adenocarcinoma esophageal squamous cell carcinoma esophagus cancer exon gastroesophageal cancer gene gene expression high performance liquid chromatography human human cell human tissue IC50 immunohistochemistry lysosome monotherapy multiple cycle treatment phase 1 clinical trial protein expression quantitative analysis reverse transcription polymerase chain reaction SGPL1 gene signal transduction sphingolipid metabolism SPHK1 gene stomach adenocarcinoma stomach cancer survival time analogs and derivatives biosynthesis drug resistance Esophageal Neoplasms female gene expression regulation genetics male metabolism real time polymerase chain reaction Stomach Neoplasms tumor cell line Aldehyde-Lyases Antineoplastic Agents Cell Line, Tumor Drug Resistance, Neoplasm Esophageal Neoplasms Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Lysophospholipids Male Phosphotransferases (Alcohol Group Acceptor) Real-Time Polymerase Chain Reaction RNA, Neoplasm Signal Transduction Sphingosine Stomach Neoplasms Matula, K Collie-Duguid, E Murray, G Parikh, K Grabsch, H Tan, P Lalwani, S Garau, R Ong, Y Bain, G Smith, A.-D Urquhart, G Bielawski, J Finnegan, M Petty, R Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
description |
10.1186/s12885-015-1718-7 |
author2 |
DUKE-NUS MEDICAL SCHOOL |
author_facet |
DUKE-NUS MEDICAL SCHOOL Matula, K Collie-Duguid, E Murray, G Parikh, K Grabsch, H Tan, P Lalwani, S Garau, R Ong, Y Bain, G Smith, A.-D Urquhart, G Bielawski, J Finnegan, M Petty, R |
format |
Article |
author |
Matula, K Collie-Duguid, E Murray, G Parikh, K Grabsch, H Tan, P Lalwani, S Garau, R Ong, Y Bain, G Smith, A.-D Urquhart, G Bielawski, J Finnegan, M Petty, R |
author_sort |
Matula, K |
title |
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
title_short |
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
title_full |
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
title_fullStr |
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
title_full_unstemmed |
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
title_sort |
regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/181428 |
_version_ |
1821232074712940544 |